GLIS2 and breast carcinoma: Next, we investigated whether NKL/GrB-T cells also display enhanced cytotoxic activity against EGFR-expressing tumor cells employing established human MDA-MB468 breast carcinoma and A431 squamous cell carcinoma cells as targets.